Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

‘Caution in use’ alert issued for Inhixa solution for injection

‘Caution in use’ alert issued for Inhixa solution for injection

April 20 2018 A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin...

Views sought on improving health services for people with sensory loss

Views sought on improving health services for people with sensory loss

April 20 2018 Primary care professionals are being asked for views on how to help improve...

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

April 20 2018 Doctors have not been prevented from prescribing over-the counter medicines, but...

Epipen manufacturing delays causing stock shortage

Epipen manufacturing delays causing stock shortage

April 17 2018 A manufacturing delay is causing problems around availability of Epipen (Senior)...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:48
  • ‘Caution in use’ alert issued for Inhixa solution for injection

    ‘Caution in use’ alert issued for Inhixa solution for injection

    Friday, 20 April 2018 16:43
  • Views sought on improving health services for people with sensory loss

    Views sought on improving health services for people with sensory loss

    Friday, 20 April 2018 16:39
  • Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Friday, 20 April 2018 16:31
  • Epipen manufacturing delays causing stock shortage

    Epipen manufacturing delays causing stock shortage

    Tuesday, 17 April 2018 08:53

a alert imageJanuary 11 2018

Healthcare professionals are being asked to be extra vigilant when prescribing or dispensing medicines with commonly confused drug names.

The MHRA’s latest Drug Safety Update gives a list of common errors of names that sound alike or look alike:

clobazam (benzodiazepine)

clonazepam (antiepileptic drug)

atenolol (beta blocker)

amlodipine (calcium channel blocker)

propranolol (beta blocker)

prednisolone (corticosteroid)

risperidone (antipsychotic)

ropinirole (dopamine agonist)

sulfadiazine (antibiotic)

sulfasalazine (disease-modifying anti-rheumatic drug)

amlodipine (indicated for hypertension and angina)         

nimodipine (indicated for the prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage)

“We are aware of recent cases, including cases with fatal outcomes, in which patients have received the wrong medicine due to confusion between similarly named or sounding brand or generic names,” said the MHRA. “Since our last Drug Safety Update on drug-name confusion in 2013, we have received Yellow Card reports of harm following confusion between the drugs listed in the table.”

The MHRA says “if pharmacists have any doubt about which medicine is intended, contact the prescriber before dispensing the drug.” They should also “follow local and professional guidance in relation to checking the right medicine has been dispensed to a patient.”

Health professionals are asked to “report suspected adverse drug reactions where harm has occurred as a result of a medication error on a Yellow Card or via local risk management systems that feed into the National Reporting and Learning System.”

Links:
MHRA Drug Safety Update: monthly PDF newsletters        
MHRA Drug Safety Update: monthly PDF newsletter. January 6 2018. 11;6.                 
Drug name confusion DSU – January 2018              
Drug name confusion DSU – April 2013  

Professional News

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested. 
April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested.  GFF prescribing is less likely to occur in areas...